Amgen stock up despite earnings miss for second quarter

You are here: Home > Biotech > Current Article

Amgen stock up despite earnings miss for second quarter

By Staff Report / Tuesday, July 30th, 2019 / Comments Off on Amgen stock up despite earnings miss for second quarter

A hike in Amgen’s full-year guidance sent shares edging up in after-hours trading July 30, despite a 3 percent dip in revenues and an earnings miss for its second quarter. The Thousand Oaks biotech reported $5.87 billion in revenues for the quarter ended June 30, down from $6.06 billion in the previous second quarter, but…

This article is only available to Business Times subscribers

Subscribers: LOG IN or REGISTER for complete digital access.
Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists.
Check the STATUS of your Subscription Account.